CryoPort financials
$17.32−0.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $176.2M | $156.8M | $168.7M | $237.3M | $222.6M | $78.7M | $33.9M | $19.6M | $12.0M | $7.7M |
| Gross profit | $83.1M | $69.7M | $75.3M | $103.9M | $96.6M | $36.3M | $17.4M | $10.2M | $6.0M | $3.1M |
| Gross margin | 47.1% | 44.4% | 44.7% | 43.8% | 43.4% | 46.2% | 51.1% | 52.2% | 49.9% | 40.4% |
| Operating income | -$36.8M | -$121.7M | -$100.5M | -$31.9M | -$17.8M | -$30.0M | -$17.7M | -$8.6M | -$7.9M | -$8.8M |
| Net income | $70.3M | -$122.8M | -$107.6M | -$45.3M | -$283.7M | -$75.0M | -$18.3M | -$9.6M | -$7.9M | -$13.2M |
| Net margin | 39.9% | −78.3% | −63.8% | −19.1% | −127.5% | −95.3% | −54.0% | −48.7% | −66.1% | −171.8% |
| Diluted EPS | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 | $-1.94 | $-0.55 | $-0.34 | $-0.34 | $-0.93 |
| EBITDA | -$9.1M | -$27.1M | -$23.5M | -$9.1M | $2.4M | -$20.1M | -$15.3M | -$7.8M | -$7.2M | -$8.4M |
| Operating cash flow | -$8.6M | -$16.3M | -$757.0K | -$1.9M | $8.1M | -$14.9M | -$1.3M | -$3.4M | -$3.6M | -$5.7M |
| Free cash flow | -$25.0M | -$33.6M | -$39.5M | -$24.0M | -$15.8M | -$23.8M | -$6.7M | -$6.3M | -$5.3M | -$6.8M |
| Diluted shares | 50.1M | 49.3M | 48.7M | 49.0M | 45.9M | 38.6M | 33.4M | 28.2M | 23.0M | 14.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $250.5M | $34.1M | $46.3M | $36.6M | $139.1M | $36.9M |
| Short-term investments | $160.7M | $216.5M | $410.4M | $486.7M | $489.7M | $56.4M |
| Total debt | $187.5M | $200.6M | $381.3M | $407.5M | $405.4M | $116.4M |
| Total assets | $765.0M | $703.5M | $957.7M | $1.04B | $1.11B | $552.4M |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M | $169.7M |
| Shareholders' equity | $502.6M | $401.9M | $489.0M | $555.8M | $641.8M | $382.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology